Citigroup Inc Qiagen N.V. Transaction History

Citigroup Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$35.55 - $43.57 $27.3 Million - $33.5 Million	769,045 Added 119.66%	1,411,713 $61.3 Million
Q3 2023 Nov 09, 2023	BUY	$39.13 - $47.24 $5.14 Million - $6.2 Million	131,322 Added 25.68%	642,668 $26 Million
Q2 2023 Aug 10, 2023	SELL	$43.93 - $46.76 $49.1 Million - $52.2 Million	-1,117,013 Reduced 68.6%	511,346 $23 Million
Q1 2023 May 11, 2023	BUY	$45.29 - $50.76 $37.5 Million - $42 Million	827,536 Added 103.34%	1,628,359 $74.8 Million
Q4 2022 Feb 09, 2023	BUY	$41.91 - $50.48 $12.2 Million - $14.7 Million	291,244 Added 57.15%	800,823 $39.9 Million
Q3 2022 Nov 10, 2022	SELL	$40.9 - $50.42 $18.7 Million - $23 Million	-457,107 Reduced 47.29%	509,579 $21 Million
Q2 2022 Aug 10, 2022	SELL	$42.98 - $49.77 $1.39 Million - $1.61 Million	-32,259 Reduced 3.23%	966,686 $45.6 Million
Q1 2022 May 12, 2022	BUY	$42.23 - $54.3 $4.31 Million - $5.54 Million	102,021 Added 11.37%	998,945 $48.9 Million
Q4 2021 Feb 10, 2022	BUY	$50.62 - $56.47 $20.1 Million - $22.4 Million	397,536 Added 79.6%	896,924 $49.9 Million
Q3 2021 Nov 10, 2021	BUY	$46.55 - $56.83 $23.2 Million - $28.4 Million	499,388 New	499,388 $25.8 Million

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.4B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.